A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy andSafety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, ElderlyHospitalized Patients With Influenza A Infection

Project: Research project

Description

A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, Elderly Hospitalized Patients With Influenza A Infection
StatusActive
Effective start/end date10/1/1810/30/21

Funding

  • JANSSEN RESEARCH & DEVELOPMENT, LLC

Fingerprint

Standard of Care
Human Influenza
Multicenter Studies
Placebos
Safety
Infection
Therapeutics